Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  PDF of this article
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Published comments/rapid response letters
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box Social Bookmarking
 Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter
What's this?
box PubMed
Articles in PubMed by Author:
 arrow  Calonge, N.
space
 arrow  Randhawa, G.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

IN THE BALANCE

The Meaning of the U.S. Preventive Services Task Force Grade I Recommendation: Screening for Hepatitis C Virus Infection

right arrow Ned Calonge, MD, MPH, and Gurvaneet Randhawa, MD, MPH

2 November 2004 | Volume 141 Issue 9 | Pages 718-719

The U.S. Preventive Services Task Force (USPSTF) formulates evidence-based recommendations for clinical preventive services. These recommendations are communicated by letter grades that reflect the quality of evidence and the magnitude of net health benefit expected from delivering the preventive service. When the USPSTF finds insufficient evidence to determine the balance of health benefits or harms of delivering a preventive service, because of a lack of studies, poor-quality studies, or good-quality studies with conflicting results, the USPSTF assigns the service an I letter grade. The USPSTF found insufficient evidence to recommend for or against screening for hepatitis C virus infection in high-risk individuals (I letter grade). This recommendation reflects the need for further research that would provide adequate evidence to assess the net health benefit for persons screened for hepatitis C virus infection.

Author and Article Information
space

From the Colorado Department of Public Health and Environment, Denver, Colorado, and the Agency for Healthcare Research and Quality, Rockville, Maryland.

Disclaimer: The authors of this article are responsible for its contents, including any clinical or treatment recommendations. No statement in this article should be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.

Potential Financial Conflicts of Interest: None disclosed.

Requests for Single Reprints: Reprints are available from the USPSTF Web site (http://www.preventiveservices.ahrq.gov) and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (800-358-9295).

Current Author Addresses: Dr. Calonge: Chair, U.S. Preventive Services Task Force, c/o Program Director, USPSTF, Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, MD 20850.

Dr. Randhawa: Center for Outcomes and Evidence, Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, MD 20850.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related articles in Annals:

In the Balance
Testing for Hepatitis C Virus Infection Should Be Routine for Persons at Increased Risk for Infection
Miriam J. Alter, Leonard B. Seeff, Bruce R. Bacon, David L. Thomas, Michael O. Rigsby, AND Adrian M. Di Bisceglie
Annals 2004 141: 715-717. [ABSTRACT][Full Text]  



This article has been cited by other articles:


Home page
Trauma Violence AbuseHome page
M. B. Phelan
Screening for Intimate Partner Violence in Medical Settings
Trauma Violence Abuse, April 1, 2007; 8(2): 199 - 213.
[Abstract] [PDF]


Home page
PsychosomaticsHome page
M. A. Rifai, J. K. Moles, L. P. Lehman, and B. J. Van der Linden
Hepatitis C screening and treatment outcomes in patients with substance use/dependence disorders.
Psychosomatics, March 1, 2006; 47(2): 112 - 121.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
T. Wong and S. S. Lee
Hepatitis C: a review for primary care physicians
Can. Med. Assoc. J., February 28, 2006; 174(5): 649 - 659.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. L. Koretz and T. O. Lipman
Update in Gastroenterology and Hepatology
Ann Intern Med, September 6, 2005; 143(5): 347 - 354.
[Full Text] [PDF]


Home page
FocusHome page
M. A. Rifai and D. L. Rosenstein
Hepatitis C and Psychiatry
Focus, April 1, 2005; 3(2): 194 - 202.
[Abstract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

Importance of Screening High-Risk Patients for HCV
Amy L. Webb
Annals Online, 17 Dec 2004 [Full text]



 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2004 by the American College of Physicians.